GRAL 10-DAY DEADLINE ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline

Hagens Berman has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) alleging the company misled investors about its NHS-Galleri cancer screening trial's design and efficacy. GRAIL failed to meet the trial's primary endpoint on February 19, 2026, and admitted the three-year follow-up period was insufficient. The stock collapsed 50.55% in a single trading session, erasing $2.2 billion in market capitalization. The lead plaintiff deadline is August 4, 2026.